Fractyl Health, Inc.
GUTS
Rank in Stocks
#28228
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for... Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Share Price
$0.8971
Last synced: 2026-11-09
Market Cap
$11.90M
Change (1 day)
-3.52%
Change (1 year)
-18.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fractyl Health, Inc. (GUTS)
Category
Healthcare
Operating Margin for Fractyl Health, Inc. (GUTS)
Operating Margin as of November 2026 TTM: 0.00%
According to Fractyl Health, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Fractyl Health, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -100,570.97% | 137.40% |
| 2023 | -42,363.33% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Fractyl Health, Inc.'s operating margin
What was Fractyl Health, Inc.'s operating margin in 2025?
In 2025, Fractyl Health, Inc.'s operating margin was 0.00%, compared with -100,570.97% in 2024.
How has Fractyl Health, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Fractyl Health, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2024 (-100,570.97%).
How does Fractyl Health, Inc.'s operating margin compare with similar companies?
Fractyl Health, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.